A. Luckish

Effects of long-term risedronate treatment on serum ferritin levels in postmenopausal women with osteoporosis: the impact of cardiovascular risk factor load

Z. Feldbrin, M. Shargorodsky, A. Luckish, 2016, Menopause.

Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women.

M. Boaz, M. Shargorodsky, Z. Matas, 2009, Atherosclerosis.

Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors.

M. Shargorodsky, Z. Matas, R. Cernes, 2008, Bone.